Impact of IL28B polymorphisms on response to peginterferon and ribavirin in HIV-hepatitis C virus-coinfected patients with prior nonresponse or relapse

AIDS

Volumn 25, Issue 8, 2011, Pages 1131-1133

  Labarga, Pablo ^a   Barreiro, Pablo ^a   Mira, José A ^b   Vispo, Eugenia ^a   Rallón, Norma ^a   Neukam, Karin ^b   Camacho, Angela ^c   Caruz, Antonio ^d   Rodriguez Novoa, Sonia ^a   Pinilla, Javier ^e   Rivero, Antonio ^c   Benito, José M ^a   Pineda, Juan A ^b   Soriano, Vincent ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^d UNIVERSITY OF JAÉN   (Spain)

^e HOSPITAL SAN PEDRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 28B; PEGINTERFERON ALPHA; RIBAVIRIN;

ADULT; ARTICLE; FEMALE; GENOTYPE; HEPATITIS C; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FIBROSIS; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE;

EID: 85027947842     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283471d83     Document Type: Article

References (12)

1. Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, et al. Liver fibrosis progression in HIV and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999; 30:1054-1058. (Pubitemid 29458296)
2. Soriano V, Puoti M, Sulkowski M, Mauss S, Cacoub P, Cargnel A, et al. Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel. AIDS 2007; 21:1073-1089. (Pubitemid 46763278)
3. Labarga P, Vispo E, Barreiro P, Rodŕguez-Novoa S, Pinilla J, Morello J, et al. Rate and predictors of success in the retreatment of chronic hepatitis C virus in HIV/hepatitis C virus coinfected patients with prior nonresponse or relapse. J Acquir Immune Defic Syndr 2010; 53:364-368.
4. Ge D, Fellay J, Thompson A, Simon J, Shianna K, Urban T, et al. Genetic variation in IL28B predicts hepatitis C treatmentinduced viral clearance. Nature 2009; 461:399-401.
5. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate M, et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 2009; 41:1100-1104.
6. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 2009; 41:1105-1109.
7. Rallón N, Naggie S, Benito J, Medrano J, Restrepo C, Goldstein D, et al. Association of a single nucleotide polymorphism near interleukin-28B with response to hepatitis C therapy in HIV/ hepatitis C virus coinfected patients. AIDS 2010; 24:F23-29.
8. Pineda J, Caruz A, Rivero A, Neukam K, Salas I, Camacho A, et al. Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus. Clin Infect Dis 2010; 51:788-795.
9. Chevaliez S, Bouvier-Alias M, Brillet R, Pawlotsky JM. Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice. PLoS One 2009; 4:e8209.
10. Morello J, Rodriguez-Novoa S, Cantillano A, Gonzalez-Pardo G, Jimenez-Nacher I, Soriano V. Measurement of ribavirin plasma concentrations by high-performance liquid chromatography using a novel solid-phase extraction method in patients treated for chronic hepatitis C. Ther Drug Monit 2007; 29:802-806. (Pubitemid 350190858)
11. Livak K. Allelic discrimination using fluorogenic probes and the 50 nuclease assay. Genet Anal 1999; 14:143-149. (Pubitemid 29095371)
12. McCarthy J, Li J, Thompson A, Suchindran S, Lao X, Patel K, et al. Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin. Gastroenterology 2010; 138:2307-2314.